Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical adalimumab for chronic lower limb ulcers
DRKS00000583Phase 2Terminated
- Sponsor
- Leipzig University
- Start
- Nov 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in leg ulcer, sponsored by Leipzig University. Started Nov 2010; status: terminated.
02
Drugs
03
Conditions
leg ulcer
Beyond the preview
Go deeper on DRKS00000583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000583.